2,3-diphosphoglycerate has been researched along with Coronary Disease in 9 studies
2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)
2,3-bisphosphoglyceric acid : A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jürgensen, HJ | 1 |
| Wimberley, PD | 1 |
| Brodthagen, U | 1 |
| Zhang, J | 1 |
| Path, G | 1 |
| Chepuri, V | 1 |
| Xu, Y | 1 |
| Yoshiyama, M | 1 |
| Bache, RJ | 1 |
| From, AH | 1 |
| Uğurbil, K | 1 |
| Beder, I | 1 |
| Mataseje, A | 1 |
| Kittova, M | 1 |
| Carsky, J | 1 |
| Fischer, V | 1 |
| Sisetskiĭ, AP | 1 |
| Artiuk, VP | 1 |
| Sakharchuk, II | 1 |
| Starodub, NF | 1 |
| Moskowitz, WB | 1 |
| Mosteller, M | 1 |
| Schieken, RM | 1 |
| Bossano, R | 1 |
| Hewitt, JK | 1 |
| Bodurtha, JN | 1 |
| Segrest, JP | 1 |
| Jiang, SS | 1 |
| Yu, GR | 2 |
| Zhang, SH | 1 |
| Korkushko, OV | 1 |
| Ivanov, LA | 1 |
| Pisaruk, AV | 1 |
| Lasitsa, TS | 1 |
| Koshu, M | 1 |
| Sugimoto, T | 1 |
| Terada, Y | 1 |
| Uraoka, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00005242] | 0 participants | Observational | 1989-04-30 | Completed | |||
| [NCT00005161] | 0 participants | Observational | 1983-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 other studies available for 2,3-diphosphoglycerate and Coronary Disease
| Article | Year |
|---|---|
Oxyhaemoglobin equilibrium and chronic beta-adrenoceptor blockade in coronary heart disease.
Topics: 2,3-Diphosphoglycerate; Adrenergic beta-Antagonists; Adult; Aged; Coronary Disease; Diphosphoglyceri | 1983 |
Responses of myocardial high energy phosphates and wall thickening to prolonged regional hypoperfusion induced by subtotal coronary stenosis.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Dip | 1993 |
[Oxygen transport values in patients with surgery performed under extracorporeal blood circulation].
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Cell Count; Coronary Disease; Extracorporeal C | 2000 |
[The phosphate and methemoglobin content of the erythrocytes in patients with ischemic heart disease].
Topics: 2,3-Diphosphoglycerate; Chronic Disease; Coronary Disease; Diphosphoglyceric Acids; Drug Therapy, Co | 1991 |
Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study.
Topics: 2,3-Diphosphoglycerate; Child; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diphosphoglycer | 1990 |
Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study.
Topics: 2,3-Diphosphoglycerate; Child; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diphosphoglycer | 1990 |
Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study.
Topics: 2,3-Diphosphoglycerate; Child; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diphosphoglycer | 1990 |
Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study.
Topics: 2,3-Diphosphoglycerate; Child; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diphosphoglycer | 1990 |
[Changes in the deformability of erythrocytes and 2,3-DPG in coronary artery stenosis].
Topics: 2,3-Diphosphoglycerate; Coronary Disease; Diphosphoglyceric Acids; Drug Combinations; Drugs, Chinese | 1989 |
[Clinical and experimental study on the effect of Salvia miltiorrhiza on microcirculation and 2,3 diphosphoglyceric acid in patients with coronary heart disease].
Topics: 2,3-Diphosphoglycerate; Animals; Coronary Disease; Diphosphoglyceric Acids; Drug Combinations; Drugs | 1988 |
[Mechanisms of the effect of propranolol on the oxygen transport function of the blood in elderly patients with ischemic heart disease].
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Age Factors; Aged; Biological Transport; Blood Gluco | 1986 |
Effect of dilazep on hemoglobin-oxygen affinity in patients with ischemic heart disease.
Topics: 2,3-Diphosphoglycerate; Administration, Oral; Adult; Aged; Aldosterone; Angina Pectoris; Azepines; C | 1985 |